Dual blockade of the EGFR and COX-2 pathways: A phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer

Emily Chan, Bonnie LaFleur, Mace L. Rothenberg, Nipun Merchant, Albert Craig Lockhart, Bakula Trivedi, Christine H. Chung, Robert J. Coffey, Jordan D. Berlin

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Dual blockade of the EGFR and COX-2 pathways: A phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences